SANUWAVE Health's EBITDA per Share for the
three
months ended in Dec. 2023 was $0.02.
During the past 12 months, SANUWAVE Health's average EBITDA Per Share Growth Rate was -233.30% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 45.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of SANUWAVE Health was 55.70% per year. The lowest was -833.30% per year. And the median was 25.05% per year.
Competitive Comparison
For the Medical Devices subindustry, SANUWAVE Health's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health 5-Year EBITDA Growth Rate Distribution
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's 5-Year EBITDA Growth Rate falls into.
SANUWAVE Health 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
SANUWAVE Health (OTCPK:SNWV) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
SANUWAVE Health 5-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of SANUWAVE Health's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
SANUWAVE Health (SANUWAVE Health) Business Description
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNWV has been successfully added to your